Inhibitory and stimulatory micropeptides preferentially bind to different conformations of the cardiac calcium pump

[1]  L. M. Espinoza-Fonseca,et al.  Fluorescence lifetime imaging microscopy reveals sodium pump dimers in live cells , 2022, The Journal of biological chemistry.

[2]  G. Veglia,et al.  A kink in DWORF helical structure controls the activation of the sarcoplasmic reticulum Ca2+-ATPase , 2021, Structure.

[3]  M. J. Lemieux,et al.  Dwarf open reading frame (DWORF) is a direct activator of the sarcoplasmic reticulum calcium pump SERCA , 2021, eLife.

[4]  G. Veglia,et al.  A Kink in DWORF Helical Structure Controls the Activation of the Sarco-plasmic Reticulum Ca2+-ATPase , 2021, bioRxiv.

[5]  Daniel R. Stroik,et al.  The transmembrane peptide DWORF activates SERCA2a via dual mechanisms , 2021, The Journal of biological chemistry.

[6]  M. Gautel,et al.  When is an obscurin variant pathogenic? The impact of Arg4344Gln and Arg4444Trp variants on protein–protein interactions and protein stability , 2021, Human molecular genetics.

[7]  J. Schmitt,et al.  Molecular Noise-Filtering in the β-adrenergic Signaling Network by Phospholamban Pentamers , 2020, bioRxiv.

[8]  L. M. Espinoza-Fonseca,et al.  Atomistic Structure and Dynamics of the Ca2+-ATPase Bound to Phosphorylated Phospholamban , 2020, International journal of molecular sciences.

[9]  E. Olson,et al.  Gene Therapy with the DWORF Micropeptide Attenuates Cardiomyopathy in Mice. , 2020, Circulation research.

[10]  Jeffrey J. Gray,et al.  Protein docking and steered molecular dynamics suggest alternative phospholamban-binding sites on the SERCA calcium transporter , 2020, The Journal of Biological Chemistry.

[11]  C. Charles,et al.  Cardiovascular effects of DWORF (dwarf open reading frame) peptide in normal and ischaemia/reperfused isolated rat hearts , 2019, Peptides.

[12]  Deo R. Singh,et al.  Newly Discovered Micropeptide Regulators of SERCA Form Oligomers but Bind to the Pump as Monomers. , 2019, Journal of molecular biology.

[13]  A. Zima,et al.  Novel approach for quantification of endoplasmic reticulum Ca2+ transport. , 2019, American journal of physiology. Heart and circulatory physiology.

[14]  Talley J. Lambert,et al.  FPbase: a community-editable fluorescent protein database , 2019, Nature Methods.

[15]  Bin Sun,et al.  Thermodynamics of Cation Binding to the Sarcoendoplasmic Reticulum Calcium ATPase Pump and Impacts on Enzyme Function. , 2019, Journal of chemical theory and computation.

[16]  E. Olson,et al.  The DWORF micropeptide enhances contractility and prevents heart failure in a mouse model of dilated cardiomyopathy , 2018, eLife.

[17]  L. M. Espinoza-Fonseca,et al.  Structural basis for relief of phospholamban-mediated inhibition of the sarcoplasmic reticulum Ca2+-ATPase at saturating Ca2+ conditions , 2018, The Journal of Biological Chemistry.

[18]  A. Zima,et al.  Redistribution of SERCA calcium pump conformers during intracellular calcium signaling , 2018, The Journal of Biological Chemistry.

[19]  Peter M Kekenes-Huskey,et al.  Computational modeling of amylin-induced calcium dysregulation in rat ventricular cardiomyocytes. , 2017, Cell calcium.

[20]  S. Robia,et al.  Cardiac Calcium ATPase Dimerization Measured by Cross-Linking and Fluorescence Energy Transfer. , 2016, Biophysical journal.

[21]  A. Zima,et al.  R-CEPIA1er as a new tool to directly measure sarcoplasmic reticulum [Ca] in ventricular myocytes. , 2016, American journal of physiology. Heart and circulatory physiology.

[22]  Akshay S. Desai,et al.  Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial , 2016, The Lancet.

[23]  Stephen C. Cannon,et al.  A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle , 2016, Science.

[24]  S. Harding,et al.  The Current and Future Landscape of SERCA Gene Therapy for Heart Failure: A Clinical Perspective. , 2015, Human gene therapy.

[25]  Tory M. Schaaf,et al.  Discovery of Enzyme Modulators via High-Throughput Time-Resolved FRET in Living Cells , 2014, Journal of biomolecular screening.

[26]  G. Veglia,et al.  Allosteric regulation of SERCA by phosphorylation-mediated conformational shift of phospholamban , 2013, Proceedings of the National Academy of Sciences.

[27]  P. Vangheluwe,et al.  Distinct Roles of the C-terminal 11th Transmembrane Helix and Luminal Extension in the Partial Reactions Determining the High Ca2+ Affinity of Sarco(endo)plasmic Reticulum Ca2+-ATPase Isoform 2b (SERCA2b)* , 2012, The Journal of Biological Chemistry.

[28]  David D. Thomas,et al.  Nucleotide Activation of the Ca-ATPase* , 2012, The Journal of Biological Chemistry.

[29]  Mark E. Anderson,et al.  CaMKII effects on inotropic but not lusitropic force frequency responses require phospholamban. , 2012, Journal of molecular and cellular cardiology.

[30]  David D. Thomas,et al.  2-Color Calcium Pump Reveals Closure of the Cytoplasmic Headpiece with Calcium Binding , 2012, PloS one.

[31]  R. Hajjar,et al.  Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome , 2012, Circulation research.

[32]  A. Zima,et al.  Phospholamban Binds with Differential Affinity to Calcium Pump Conformers* , 2011, The Journal of Biological Chemistry.

[33]  David D. Thomas,et al.  Oligomeric Interactions of Sarcolipin and the Ca-ATPase* , 2011, The Journal of Biological Chemistry.

[34]  G. Veglia,et al.  Structural topology of phospholamban pentamer in lipid bilayers by a hybrid solution and solid-state NMR method , 2011, Proceedings of the National Academy of Sciences.

[35]  L. Masterson,et al.  Lethal Arg9Cys phospholamban mutation hinders Ca2+-ATPase regulation and phosphorylation by protein kinase A , 2011, Proceedings of the National Academy of Sciences of the United States of America.

[36]  D. Bers,et al.  Phosphomimetic Mutations Enhance Oligomerization of Phospholemman and Modulate Its Interaction with the Na/K-ATPase* , 2011, The Journal of Biological Chemistry.

[37]  L. Jones,et al.  Ca2+ Binding to Site I of the Cardiac Ca2+ Pump Is Sufficient to Dissociate Phospholamban* , 2009, The Journal of Biological Chemistry.

[38]  Z. Hou,et al.  Phosphomimetic Mutations Increase Phospholamban Oligomerization and Alter the Structure of Its Regulatory Complex* , 2008, Journal of Biological Chemistry.

[39]  D. Bers,et al.  Phospholamban Oligomerization, Quaternary Structure, and Sarco(endo)plasmic Reticulum Calcium ATPase Binding Measured by Fluorescence Resonance Energy Transfer in Living Cells* , 2008, Journal of Biological Chemistry.

[40]  K. Campbell,et al.  Förster Transfer Recovery Reveals That Phospholamban Exchanges Slowly From Pentamers but Rapidly From the SERCA Regulatory Complex , 2007, Circulation research.

[41]  David D. Thomas,et al.  Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA. , 2006, Journal of molecular biology.

[42]  I. V. Negrashov,et al.  Direct detection of phospholamban and sarcoplasmic reticulum Ca-ATPase interaction in membranes using fluorescence resonance energy transfer. , 2004, Biochemistry.

[43]  A. Hovnanian,et al.  Dissection of the Functional Differences between Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA) 1 and 2 Isoforms and Characterization of Darier Disease (SERCA2) Mutants by Steady-state and Transient Kinetic Analyses* , 2003, Journal of Biological Chemistry.

[44]  Y. Sugita,et al.  Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  D. Ferrington,et al.  Comparable levels of Ca-ATPase inhibition by phospholamban in slow-twitch skeletal and cardiac sarcoplasmic reticulum. , 2002, Biochemistry.

[46]  R. Cornea,et al.  Close Proximity between Residue 30 of Phospholamban and Cysteine 318 of the Cardiac Ca2+ Pump Revealed by Intermolecular Thiol Cross-linking* , 2002, The Journal of Biological Chemistry.

[47]  T. Vorherr,et al.  NMR Solution Structure of Phospholamban , 2000 .

[48]  D. Maclennan,et al.  Physical Interactions between Phospholamban and Sarco(endo)plasmic Reticulum Ca2+-ATPases Are Dissociated by Elevated Ca2+, but Not by Phospholamban Phosphorylation, Vanadate, or Thapsigargin, and Are Enhanced by ATP* , 2000, The Journal of Biological Chemistry.

[49]  W. Lew,et al.  Phospholamban-to-SERCA2 ratio controls the force-frequency relationship. , 1999, American journal of physiology. Heart and circulatory physiology.

[50]  D. Maclennan,et al.  Phospholamban Inhibitory Function Is Activated by Depolymerization* , 1997, The Journal of Biological Chemistry.

[51]  D. D. Thomas,et al.  Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers. , 1997, Biochemistry.

[52]  J. East,et al.  An investigation of the mechanism of inhibition of the Ca(2+)-ATPase by phospholamban. , 1996, The Biochemical journal.

[53]  A. M. Mata,et al.  The Modulation of Ca2+ Binding to Sarcoplasmic Reticulum ATPase by ATP Analogues Is pH-dependent (*) , 1995, The Journal of Biological Chemistry.

[54]  H. Drexler,et al.  Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. , 1994, Circulation research.

[55]  Y. Sagara,et al.  Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases. Effect of a phospholamban antibody on enzyme activation by Ca2+. , 1993, The Journal of biological chemistry.

[56]  G. Flik,et al.  CHELATOR: an improved method for computing metal ion concentrations in physiological solutions. , 1992, BioTechniques.

[57]  N. Alpert,et al.  Altered Myocardial Force‐Frequency Relation in Human Heart Failure , 1992, Circulation.

[58]  E. Carafoli,et al.  Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum , 1989, Nature.

[59]  A. J. Brady,et al.  Contractile force measured in unskinned isolated adult rat heart fibres , 1979, Nature.

[60]  A. Katz,et al.  Phosphorylation of a 22,000-dalton component of the cardiac sarcoplasmic reticulum by adenosine 3':5'-monophosphate-dependent protein kinase. , 1975, The Journal of biological chemistry.

[61]  E. Kranias,et al.  Phospholamban: a major determinant of the cardiac force-frequency relationship. , 2000, American journal of physiology. Heart and circulatory physiology.

[62]  Godfrey L. Smith,et al.  Enhanced phosphorylation of phospholamban and downregulation of sarco/endoplasmic reticulum Ca2+ ATPase type 2 (SERCA 2) in cardiac sarcoplasmic reticulum from rabbits with heart failure. , 1999, Cardiovascular research.

[63]  R. Bick,et al.  Phosphorylation of a 100 000 dalton component and its relationship to calcium transport in sarcoplasmic reticulum from rabbit skeletal muscle. , 1980, Biochimica et biophysica acta.

[64]  R. Albers.  Biochemical aspects of active transport. , 1967, Annual review of biochemistry.

[65]  H. P. Bowditch.  Über die Eigenthümlichkeiten der Reizbarkeit, welche die Muskelfasern des Herzens zeigen , 1871 .